Digitisation | June 03, 2021
Lupin to foray into the digital healthcare space
The company recently incorporated a new entity in the name of Lupin Digital Health Limited
The company recently incorporated a new entity in the name of Lupin Digital Health Limited
Aurobindo has one of the most enduring generics ecosystems among peers
The company's operating revenue for Q4 FY21 was Rs. 330.2 crore
7.94 crore doses were made available to the states in May 2021
Adjusted PAT declined 18.8% YoY
The company has posted net profit of Rs.1140.01 crores during FY 2020-21
The patients can check to see if the product purchased by them is genuine or not by scratching the surface and verifying the code through the app or the website
For the year ended March 31, 2021, consolidated revenue was at Rs. 10,943.9 crores as against Rs. 10,641 crores, recording an increase of 2.8% over the previous corresponding period
Dr. Sharvil Patel cites the example of prescriptions being handed over to patients despite unavailability of enough stock of such medicines
It is expected that the drug substance would be available from August 2021 which will be supplied back to Bharat Biotech for producing COVAXIN
Subscribe To Our Newsletter & Stay Updated
